Alzheimer’s Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-β Production
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04579-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Shouchao Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Third Department of Neurology, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Alzheimer Disease, Cognitive Dysfunction, Amyloid beta-Peptides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Doctoral Cooperation Project of Central People's Hospital of Zhanjiang, Zhanjiang City Science and Technology Development Special Fund Competitive Allocation Project, GuangDong Basic and Applied Basic Research Foundation.
Themen: Demenz
Abstract (Originalsprache)
Although our understanding of the molecular biology of Alzheimer's disease (AD) continues to improve, the etiology of the disease, particularly the involvement of gut microbiota disturbances, remains a challenge. Outer membrane vesicles (OMVs) play a key role in central nervous system diseases, but the impact of OMVs on AD progression remains unclear. In this study, we hypothesized that AD-derived OMVs (OMVsAD) were a risk factor in AD pathology. To test our hypothesis, young APP/PS1 mice (AD mice) were given OMVsAD by gavage. Young AD mice were euthanized 120 days after gavage to assess the intestinal barrier, gut microbiota diversity, mediators of neuroinflammation, glial markers, amyloid burden, and short-chain fatty acid (SCFA) levels. Our results showed that OMVsAD accelerated cognitive dysfunction after 120 days of intragastric administration. Morris water maze experiment and new object recognition test showed that OMVsAD caused significantly poorer spatial ability learning and memory of the AD mice. We observed the OMVsAD-treated APP/PS1 mice display OMVs disrupting the intestinal barrier compared with controls of normal human-derived OMVs. Compared with the OMVsHC group, claudin-5 and ZO-1 related to the intestinal barrier were significantly downregulated in the OMVsAD group. The OMVsAD activate microglia in the cerebral cortex and hippocampus of AD mice, and the levels of IL-1β, IL-6, TNF-α, and NF-Κb were upregulated. We also found that OMVsAD increased Aβ production. 16S rRNA sequencing showed that OMVsAD negatively regulated the α- and β-diversity index of intestinal flora and reduced the levels of SCFA. OMVsAD may change the intestinal flora of young AD, damage the intestinal mucosa and blood-brain barrier, and accelerate AD neuropathological damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Department of Neurology, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China.
- Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China.
- Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
- Basic Medicine College, Guangdong Medical University, Zhanjiang, Guangdong, China.
- Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China. zhuhe1983@hust.edu.cn.
- The Third Department of Neurology, Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China. shian_yan@126.com.
Förderung
- Doctoral Cooperation Project of Central People's Hospital of Zhanjiang
- Zhanjiang City Science and Technology Development Special Fund Competitive Allocation Project
- GuangDong Basic and Applied Basic Research Foundation
- Project of Traditional Chinese Medicine Bureau of Guangdong Province
- Doctoral Cooperation Project of Central People’s Hospital of Zhanjiang
Zitieren
APA
Wei, S., Ma, X., Chen, Y., Wang, J., Hu, L., Liu, Z., Mo, L., Zhou, N., Chen, W., Zhu, H., & Yan, S. (2025). Alzheimer’s Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-β Production. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04579-6
Vancouver
Wei S, Ma X, Chen Y, Wang J, Hu L, Liu Z, et al. Alzheimer’s Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-β Production. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04579-6
BibTeX
@article{Wei2025,
author = {Wei, Shouchao and Ma, Xiaochen and Chen, Yating and Wang, Junjun and Hu, Li and Liu, Zhou and Mo, Lang and Zhou, Ning and Chen, Wenrong and Zhu, He and Yan, Shian},
title = {Alzheimer’s Disease-Derived Outer Membrane Vesicles Exacerbate Cognitive Dysfunction, Modulate the Gut Microbiome, and Increase Neuroinflammation and Amyloid-β Production},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04579-6}
}
EUVIMED